Literature DB >> 33758601

Identification of Prognosis-related Hub RNA Binding Proteins Function through Regulating Metabolic Processes in Tongue Cancer.

Tao Shen1, Meiting Wang2,3, Xiangting Wang1.   

Abstract

RNA binding proteins (RBPs) are dysregulated and associated with the occurrence and development in various malignant tumors. However, the role of RBPs in tongue cancer are largely unclear. Here, by integrating the differential gene expression analysis and the Weighted Gene Co-expression Network Analysis (WGCNA) of TCGA-retrieved RNA-seq data, we identified a total of 171 differential co-expression RBPs. Then, in a protein-protein interaction (PPI) network containing 134 nodes (RBPs) and 315 network edges (RBP-RBP interacting networks), the top 30 hub RBPs were identified using the CytoHubba plugin of Cytoscape. Furthermore, we investigated the expression and prognostic value of these RBPs and their highly correlated networks. Among them, six RBPs (PGK1, SLC20A1, LEPR, CYP19A1, ZC3H12D, and PFKM) were shown to be the prognosis-related hub RBPs (prhRBPs). Based on these hub RBPs, we constructed a prognostic model and found that the patients in the high-risk group had dramatically poor overall survival compared to those in low-risk group. In addition, we validated the prognostic model in GSE41613, another tongue cancer patient cohort from GEO datasets. The time-dependent receiver operating characteristic (ROC) analysis of the prognostic model further confirmed the predictive capability of the risk model for tongue cancer. As suggested in functional annotation analysis, we found an intensive enrichment of these prhRBPs in metabolic pathways, including AMPK, HIF-1 signaling pathway, Glycolysis, and steroid hormone biosynthesis. Together, our study revealed the underlying role of RBP in tongue cancer biology and potentially unveiled novel targets for cancer therapy. © The author(s).

Entities:  

Keywords:  RNA binding protein; metabolic process; prognostic model.; risk score; tongue cancer

Year:  2021        PMID: 33758601      PMCID: PMC7974894          DOI: 10.7150/jca.52156

Source DB:  PubMed          Journal:  J Cancer        ISSN: 1837-9664            Impact factor:   4.207


  4 in total

1.  Identification of a ZC3H12D-regulated competing endogenous RNA network for prognosis of lung adenocarcinoma at single-cell level.

Authors:  Wenhan Chen; Zhifeng Guo; Jingyang Wu; Guofu Lin; Shaohua Chen; Qinhui Lin; Jiansheng Yang; Yuan Xu; Yiming Zeng
Journal:  BMC Cancer       Date:  2022-01-28       Impact factor: 4.430

2.  Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target.

Authors:  Haizhou Wang; Yabo Zhou; Yangyang Zhang; Shilin Fang; Meng Zhang; Haiou Li; Fei Xu; Lan Liu; Jing Liu; Qiu Zhao; Fan Wang
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 13.751

3.  Quality of Life in Patients With Tongue Cancer After Surgical Treatment: A 12-Month Prospective Study.

Authors:  Dimitra Palitzika; Ioannis Tilaveridis; Maria Lavdaniti; Konstantinos Vahtsevanos; Angeliki Kosintzi; Konstantinos Antoniades
Journal:  Cureus       Date:  2022-02-23

4.  Construction and evaluation of a nomogram for predicting survival in patients with lung cancer.

Authors:  Jin Ouyang; Zhijian Hu; Jianlin Tong; Yong Yang; Juan Wang; Xi Chen; Ting Luo; Shiqun Yu; Xin Wang; Shaoxin Huang
Journal:  Aging (Albany NY)       Date:  2022-03-23       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.